The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer
Objective: CAR-T/NK cells have had limited success in the treatment of solid tumors, such as colorectal cancer (CRC), in part because of the heterogeneous nature of tumor-associated antigens that lead to antigen-negative relapse after the initial response. This barrier might be overcome by enhancing...
Gardado en:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
China Anti-Cancer Association
2023-09-01
|
| Series: | Cancer Biology & Medicine |
| Assuntos: | |
| Acceso en liña: | https://www.cancerbiomed.org/content/20/9/662 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|